|Videos|January 13, 2017
What's Exciting in the Field of MPNs?
Author(s)Ross L. Levine, M.D.
Ross L. Levine, M.D., physician-scientist, director of the Memorial Sloan Kettering (MSK) Center for Hematologic Malignancies and 2016 MPN Hero, discusses the work at his lab that he is currently excited about.
Advertisement
Ross L. Levine, M.D., physician-scientist, director of the Memorial Sloan Kettering (MSK) Center for Hematologic Malignancies and 2016 MPN Hero, discusses the work at his lab that he is currently excited about.
Levine and his team are turning their focus to the JAK2 gene to build on recent successes in the field and hopefully develop some novel approaches. They are also investigating other possible genetic mutations that can be blocked.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
3
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
4
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
5